MET and glioblastoma: Martens et al. tested the effects of a one-armed anti-c-MET antibody (OA-5D5) on the in vivo growth of GBM xenografts, and interestingly found that treatment with OA-5D5 decreased intratumoural microvessel density, despite OA-5D5 being unable to bind murine c-MET.